HESWALL & PENSBY GROUP PRACTICE
270 TELEGRAPH ROAD, HESWALL, WIRRAL
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 16 | 23 | 69.6% | |
| HF 4 | 2011 | 19 | 26 | 73.1% | |
| HF 4 | 2012 | 21 | 32 | 65.6% | |
| HF 4 | 2013 | 27 | 35 | 77.1% | |
| HF004 | 2014 | 18 | 24 | 75.0% | |
| HF004 | 2015 | 28 | 30 | 93.3% | |
| HF004 | 2016 | 64 | 70 | 91.4% | |
| HF004 | 2017 | 70 | 77 | 90.9% | |
| HF004 | 2018 | 92 | 102 | 90.2% | |
| HF004 | 2019 | 95 | 108 | 88.0% | |
| HF004 | 2020 | 89 | 104 | 85.6% | |
| HF006 | 2021 | 118 | 151 | 78.1% | |
| HF006 | 2022 | 117 | 126 | 92.9% | |
| HF006 | 2023 | 156 | 166 | 94.0% |
